Several guidelines, including the Kidney Disease: Improving Global Outcomes guidelines, recommend the evaluation of serum cystatin C-based eGFR or creatinine clearance through 24-h urine collection in addition to serum creatinine-based eGFR, and considering the direct measurement of GFR only if necessary. Here, CST3 is linked to kidney disorder.